-
www.innovations.ahrq.gov/patient-safety/resources/learning-lab/index.html
February 01, 2024 - (This process will be studied in children with autism spectrum disorder on antipsychotics.)
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2023qdr-data-sources.pdf
December 01, 2023 - 2023 National Healthcare Quality and Disparities Report Data Sources
2023 National Healthcare Quality and
Disparities Report
Data Sources
U.S. DEPARTMENT OF
HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
5600 Fishers Lane
Rockville, MD 20857
www.ahrq.gov
…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/pubs/background-2012/backgrnd2012.pdf
January 01, 2012 - Key: ADHD = attention deficit/hyperactivity disorder; AHRQ = Agency for Healthcare Research and Quality
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/chipra-primary-care-physician-reporting.pdf
December 01, 2016 - department
visits for asthma, and medication follow-up visits for attention deficit-hyperactivity disorder
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/chipra-factors-influencing-state-reporting.pdf
July 01, 2016 - • m
Follow-up care for children prescribed attention-deficit/hyperactivity Administrative m • • •
disorder
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-209-fullreport.pdf
June 01, 2019 - interventions, as well as an increased relative risk of developing attention deficit
hyperactivity disorder
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/long-term-care/resources/ontime/fallsprev/ontimefallpxreports-ig.pdf
November 09, 2017 - hemiparesis
o Paraplegia
o Multiple sclerosis
o Huntington’s disease
o Parkinson’s disease
o Seizure disorder
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-155-section-6-b-measure.pdf
January 01, 2013 - CHIPRA 155: Section 6.B, Scientific Soundness of the Measure
SECTION VI.
SCIENTIFIC SOUNDNESS OF THE MEASURE
VI.B. Validity
VI.B.1 Construct Validity
To examine construct validity, we performed compara…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-194-fullreport.pdf
April 01, 2019 - o Blood disorder.
-
www.innovations.ahrq.gov/sites/default/files/publications/files/casalino_idkeydsr.pdf
February 01, 2014 - Identifying Key Areas for Delivery System Research
Identifying Key Areas for Delivery System Research
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Road
Rockville, MD 20850
www.ahrq.gov
Work for this paper was conducte…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-0087-fullreport.pdf
October 01, 2016 - conditions across the sites were: (1) asthma; (2) depression; (3) attention
deficient hyperactivity disorder
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-156-section-6b.pdf
January 01, 2013 - not associated with improved follow-up for children diagnosed with
attention-deficit hyperactivity disorder
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-0090-fullreport.pdf
July 25, 2016 - conditions across the sites were: (1) asthma; (2) depression; (3) attention
deficient hyperactivity disorder
-
www.innovations.ahrq.gov/sites/default/files/publications/files/impguide2.pdf
September 08, 2015 - The National Evaluation of the
CHIPRA Quality Demonstration Grant Program
Designing Care
Management Entities
for Youth with Complex
Behavioral Health Needs
Grace Anglin, Adam Swinburn, Leslie Foster, Cindy Brach, and Linda Bergofsky
Implementation Guide Number 2
2
Designing Care Management Entities for Youth w…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-153-section-6b.pdf
January 01, 2013 - Section 6.B, Validity and Reliability
SECTION VI.
SCIENTIFIC SOUNDNESS OF THE MEASURE
VALIDITY
VI.B.1 “Informing” Coverage through the natural experiment of appendicitis
Administrative data from the Medicaid Analytic eXtract (MAX) is the primary data source for
states or government agencies wishing to as…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-157-section-6b.pdf
August 10, 2018 - CHIPRA 157: Section 6.B, Scientific Soundness of the Measure
SECTION VI.
SCIENTIFIC SOUNDNESS OF THE MEASURE
VI.B. Validity
Predictive Validity
We also measure validity in terms of pre…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/professionals/clinicians-providers/guidelines-recommendations/tobacco/clinicians/references/quickref/tobaqrg.pdf
April 01, 2009 - Treating Tobacco Use and Dependence: A Quick Reference Guide for Clinicians
FINAL Quick Reference guide NEW_FINAL Quick Reference guide 9/24/09 3:15 PM Page ii
FINAL Quick Reference guide NEW_FINAL Quick Reference guide 9/24/09 3:15 PM Page a
To All Clinicians
The Public Health Service-sponsored Clinical …
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2019qdr-datasources.pdf
December 01, 2020 - 2019 National Healthcare Quality and Disparities Report Data Sources
2019 National Healthcare Quality and Disparities
Report
Data Sources
U.S. DEPARTMENT OF
HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
5600 Fishers Lane
Rockville, MD 20857
www.ahrq.gov
…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/system/delivery-system-initiative/casalino/paper/casalino_idkeydsr.pdf
February 01, 2014 - Identifying Key Areas for Delivery System Research
Identifying Key Areas for Delivery System Research
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Road
Rockville, MD 20850
www.ahrq.gov
Work for this paper was conducte…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-195-fullreport.pdf
December 17, 2019 - children with a history of a medical
condition that could otherwise warrant neuroimaging (e.g., bleeding disorder